116 related articles for article (PubMed ID: 1409546)
1. A point mutation of human interferon gamma abolishes receptor recognition.
Lunn CA; Fossetta J; Dalgarno D; Murgolo N; Windsor W; Zavodny PJ; Narula SK; Lundell D
Protein Eng; 1992 Apr; 5(3):253-7. PubMed ID: 1409546
[TBL] [Abstract][Full Text] [Related]
2. A point mutation that decreases the thermal stability of human interferon gamma.
Lunn CA; Fossetta J; Murgolo N; Zavodny PJ; Lundell D; Narula SK
Protein Eng; 1992 Apr; 5(3):249-52. PubMed ID: 1409545
[TBL] [Abstract][Full Text] [Related]
3. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
[TBL] [Abstract][Full Text] [Related]
4. An active covalently linked dimer of human interferon-gamma. Subunit orientation in the native protein.
Lunn CA; Davies L; Dalgarno D; Narula SK; Zavodny PJ; Lundell D
J Biol Chem; 1992 Sep; 267(25):17920-4. PubMed ID: 1387644
[TBL] [Abstract][Full Text] [Related]
5. Carboxy-terminal truncated rhuIFN-gamma with a substitution of Gln133 or Ser132 to leucine leads to higher biological activity than in the wild type.
Slodowski O; Böhm J; Schöne B; Otto B
Eur J Biochem; 1991 Dec; 202(3):1133-40. PubMed ID: 1662603
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma variants with deletions in the AB surface loop--flexibility is a critical point for receptor binding.
Waschütza G; Dengler U; Villmann C; Böttinger H; Otto B
Eur J Biochem; 1998 Sep; 256(2):303-9. PubMed ID: 9760168
[TBL] [Abstract][Full Text] [Related]
7. Structure/function studies on recombinant human gamma interferon.
Fish EN; Banerjee K; Arakawa T; Stebbing N
Drug Des Deliv; 1988 Feb; 2(3):191-206. PubMed ID: 2855574
[TBL] [Abstract][Full Text] [Related]
8. Dissection of the extracellular human interferon gamma receptor alpha-chain into two immunoglobulin-like domains. Production in an Escherichia coli thioredoxin gene fusion expression system and recognition by neutralizing antibodies.
Williams G; Ruegg N; Birch A; Weber C; Hofstädter K; Robinson JA; Aguet M; Garotta G; Schlatter D; Huber W
Biochemistry; 1995 Feb; 34(5):1787-97. PubMed ID: 7849039
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a synthetic peptide corresponding to a receptor binding domain of mouse interferon gamma.
Magazine HI; Johnson HM
Biochemistry; 1991 Jun; 30(23):5784-9. PubMed ID: 1828370
[TBL] [Abstract][Full Text] [Related]
10. Engineered disulfide bonds in recombinant human interferon-gamma: the impact of the N-terminal helix A and the AB-loop on protein stability.
Waschütza G; Li V; Schäfer T; Schomburg D; Villmann C; Zakaria H; Otto B
Protein Eng; 1996 Oct; 9(10):905-12. PubMed ID: 8931130
[TBL] [Abstract][Full Text] [Related]
11. Importance of the loop connecting A and B helices of human interferon-gamma in recognition by interferon-gamma receptor.
Lundell D; Lunn CA; Senior MM; Zavodny PJ; Narula SK
J Biol Chem; 1994 Jun; 269(23):16159-62. PubMed ID: 8206916
[TBL] [Abstract][Full Text] [Related]
12. Interaction of truncated human interferon gamma variants with the interferon gamma receptor: crucial importance of Arg-129.
Haelewyn J; Michiels L; Verhaert P; Hoylaerts MF; Witters R; De Ley M
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):591-5. PubMed ID: 9182722
[TBL] [Abstract][Full Text] [Related]
13. An anti-idiotypic antibody with an internal image of human interferon-gamma and human interferon-gamma-like antiviral activity.
Depraetere H; Depla E; Haelewyn J; De Ley M
Eur J Biochem; 2000 Apr; 267(8):2260-7. PubMed ID: 10759849
[TBL] [Abstract][Full Text] [Related]
14. Crystallization of the complex of human IFN-gamma and the extracellular domain of the IFN-gamma receptor.
Chène C; Fountoulakis M; Döbeli H; D'Arcy B; Winkler F; D'Arcy A
Proteins; 1995 Dec; 23(4):591-4. PubMed ID: 8749856
[TBL] [Abstract][Full Text] [Related]
15. Topology of receptor binding domains of mouse IFN-gamma.
Jarpe MA; Johnson HM
J Immunol; 1990 Nov; 145(10):3304-9. PubMed ID: 1700005
[TBL] [Abstract][Full Text] [Related]
16. Proton NMR sequence-specific assignments and secondary structure of a receptor binding domain of mouse gamma-interferon.
Sakai TT; Jablonsky MJ; DeMuth PA; Krishna NR; Jarpe MA; Johnson HM
Biochemistry; 1993 Jun; 32(21):5650-5. PubMed ID: 8504085
[TBL] [Abstract][Full Text] [Related]
17. Structural elements required for receptor recognition of human interferon-gamma.
Lundell DL; Narula SK
Pharmacol Ther; 1994 Oct; 64(1):1-21. PubMed ID: 7531344
[TBL] [Abstract][Full Text] [Related]
18. Optimization of conditions for expression of recombinant interferon-γ in E.coli.
Kumar M; Singh M; Singh SB
Mol Biol Rep; 2014 Oct; 41(10):6537-43. PubMed ID: 25001590
[TBL] [Abstract][Full Text] [Related]
19. Structure and activity of glycosylated human interferon-gamma.
Arakawa T; Hsu YR; Chang D; Stebbing N; Altrock B
J Interferon Res; 1986 Dec; 6(6):687-95. PubMed ID: 3106525
[TBL] [Abstract][Full Text] [Related]
20. Human IFN-alpha protein engineering: the amino acid residues at positions 86 and 90 are important for antiproliferative activity.
Hu R; Bekisz J; Schmeisser H; McPhie P; Zoon K
J Immunol; 2001 Aug; 167(3):1482-9. PubMed ID: 11466368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
